Perspective Therapeutics granted Fast Track designation for [212Pb]PSV359

Perspective Therapeutics received Fast Track designation for [212Pb]PSV359 for treating adult patients with locally advanced unresectable and/or metastatic FAP-positive solitary fibrous tumors.